Qiagen NV Net Income
| QGEN Stock | USD 50.40 0.01 0.02% |
As of the 16th of February 2026, Qiagen NV holds the Risk Adjusted Performance of 0.1152, semi deviation of 0.8628, and Coefficient Of Variation of 744.69. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Qiagen NV, as well as the relationship between them.
Qiagen NV Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 5.2344 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 424.9 M | 446.1 M | |
| Net Income Applicable To Common Shares | 662 M | 695.1 M | |
| Net Income From Continuing Ops | 96.1 M | 91.3 M | |
| Net Income Per Share | 0.35 | 0.42 | |
| Net Income Per E B T | 0.87 | 0.62 |
Qiagen | Net Income | Build AI portfolio with Qiagen Stock |
Evaluating Qiagen NV's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Qiagen NV's fundamental strength.
Latest Qiagen NV's Net Income Growth Pattern
Below is the plot of the Net Income of Qiagen NV over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Qiagen NV financial statement analysis. It represents the amount of money remaining after all of Qiagen NV operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Qiagen NV's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Qiagen NV's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 424.88 M | 10 Years Trend |
|
Net Income |
| Timeline |
Qiagen Net Income Regression Statistics
| Arithmetic Mean | 200,244,059 | |
| Coefficient Of Variation | 88.24 | |
| Mean Deviation | 153,628,311 | |
| Median | 129,506,000 | |
| Standard Deviation | 176,698,245 | |
| Sample Variance | 31222.3T | |
| Range | 554.1M | |
| R-Value | 0.69 | |
| Mean Square Error | 17650T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 23,989,711 | |
| Total Sum of Squares | 499556.3T |
Qiagen Net Income History
Other Fundumenentals of Qiagen NV
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Qiagen NV Net Income component correlations
Qiagen Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Qiagen NV is extremely important. It helps to project a fair market value of Qiagen Stock properly, considering its historical fundamentals such as Net Income. Since Qiagen NV's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Qiagen NV's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Qiagen NV's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Life Sciences Tools & Services sector continue expanding? Could Qiagen diversify its offerings? Factors like these will boost the valuation of Qiagen NV. Anticipated expansion of Qiagen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Qiagen NV data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.219 | Dividend Share 0.263 | Earnings Share 2.04 | Revenue Per Share | Quarterly Revenue Growth 0.037 |
Investors evaluate Qiagen NV using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Qiagen NV's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Qiagen NV's market price to deviate significantly from intrinsic value.
It's important to distinguish between Qiagen NV's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Qiagen NV should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Qiagen NV's market price signifies the transaction level at which participants voluntarily complete trades.
Qiagen NV 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Qiagen NV's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Qiagen NV.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Qiagen NV on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Qiagen NV or generate 0.0% return on investment in Qiagen NV over 90 days. Qiagen NV is related to or competes with Revvity, Align Technology, Hims Hers, Biomarin Pharmaceutical, Ensign, Charles River, and Exelixis. QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide More
Qiagen NV Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Qiagen NV's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Qiagen NV upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.12 | |||
| Information Ratio | 0.1071 | |||
| Maximum Drawdown | 19.34 | |||
| Value At Risk | (2.44) | |||
| Potential Upside | 2.86 |
Qiagen NV Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Qiagen NV's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Qiagen NV's standard deviation. In reality, there are many statistical measures that can use Qiagen NV historical prices to predict the future Qiagen NV's volatility.| Risk Adjusted Performance | 0.1152 | |||
| Jensen Alpha | 0.3609 | |||
| Total Risk Alpha | 0.1441 | |||
| Sortino Ratio | 0.2464 | |||
| Treynor Ratio | (0.77) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Qiagen NV's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Qiagen NV February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1152 | |||
| Market Risk Adjusted Performance | (0.76) | |||
| Mean Deviation | 1.34 | |||
| Semi Deviation | 0.8628 | |||
| Downside Deviation | 1.12 | |||
| Coefficient Of Variation | 744.69 | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.6 | |||
| Information Ratio | 0.1071 | |||
| Jensen Alpha | 0.3609 | |||
| Total Risk Alpha | 0.1441 | |||
| Sortino Ratio | 0.2464 | |||
| Treynor Ratio | (0.77) | |||
| Maximum Drawdown | 19.34 | |||
| Value At Risk | (2.44) | |||
| Potential Upside | 2.86 | |||
| Downside Variance | 1.25 | |||
| Semi Variance | 0.7443 | |||
| Expected Short fall | (1.97) | |||
| Skewness | 4.34 | |||
| Kurtosis | 25.16 |
Qiagen NV Backtested Returns
Qiagen NV appears to be very steady, given 3 months investment horizon. Qiagen NV maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Qiagen NV, which you can use to evaluate the volatility of the company. Please evaluate Qiagen NV's Semi Deviation of 0.8628, risk adjusted performance of 0.1152, and Coefficient Of Variation of 744.69 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Qiagen NV holds a performance score of 9. The company holds a Beta of -0.43, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Qiagen NV are expected to decrease at a much lower rate. During the bear market, Qiagen NV is likely to outperform the market. Please check Qiagen NV's value at risk, and the relationship between the jensen alpha and skewness , to make a quick decision on whether Qiagen NV's historical price patterns will revert.
Auto-correlation | -0.15 |
Insignificant reverse predictability
Qiagen NV has insignificant reverse predictability. Overlapping area represents the amount of predictability between Qiagen NV time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Qiagen NV price movement. The serial correlation of -0.15 indicates that less than 15.0% of current Qiagen NV price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.15 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 12.16 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Qiagen Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Qiagen NV reported net income of 424.88 M. This is 24.5% higher than that of the Life Sciences Tools & Services sector and 145.44% higher than that of the Health Care industry. The net income for all United States stocks is 25.59% higher than that of the company.
Qiagen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Qiagen NV's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Qiagen NV could also be used in its relative valuation, which is a method of valuing Qiagen NV by comparing valuation metrics of similar companies.Qiagen NV is currently under evaluation in net income category among its peers.
Qiagen NV ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Qiagen NV's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Qiagen NV's managers, analysts, and investors.Environmental | Governance | Social |
Qiagen NV Institutional Holders
Institutional Holdings refers to the ownership stake in Qiagen NV that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Qiagen NV's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Qiagen NV's value.| Shares | Norges Bank | 2025-06-30 | 3.3 M | Allspring Global Investments Holdings, Llc | 2025-06-30 | 2.7 M | State Street Corp | 2025-06-30 | 2.1 M | Capital Research & Mgmt Co - Division 3 | 2025-06-30 | 2 M | Universal- Beteiligungs- Und Servicegesellschaft Mbh | 2025-06-30 | 2 M | Victory Capital Management Inc. | 2025-06-30 | 1.9 M | Goldman Sachs Group Inc | 2025-06-30 | 1.9 M | Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main | 2025-06-30 | 1.9 M | Sei Investments Co | 2025-06-30 | 1.8 M | Wellington Management Company Llp | 2025-06-30 | 26 M | Massachusetts Financial Services Company | 2025-06-30 | 24.5 M |
Qiagen Fundamentals
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0576 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 10.94 B | ||||
| Shares Outstanding | 206 M | ||||
| Shares Owned By Insiders | 0.44 % | ||||
| Shares Owned By Institutions | 82.54 % | ||||
| Number Of Shares Shorted | 5.99 M | ||||
| Price To Earning | 24.32 X | ||||
| Price To Book | 2.75 X | ||||
| Price To Sales | 4.97 X | ||||
| Revenue | 2.09 B | ||||
| Gross Profit | 1.39 B | ||||
| EBITDA | 717.27 M | ||||
| Net Income | 424.88 M | ||||
| Cash And Equivalents | 1.89 B | ||||
| Cash Per Share | 8.31 X | ||||
| Total Debt | 1.65 B | ||||
| Debt To Equity | 0.69 % | ||||
| Current Ratio | 1.84 X | ||||
| Book Value Per Share | 18.33 X | ||||
| Cash Flow From Operations | 654.33 M | ||||
| Short Ratio | 2.02 X | ||||
| Earnings Per Share | 2.04 X | ||||
| Price To Earnings To Growth | 0.34 X | ||||
| Target Price | 54.9 | ||||
| Number Of Employees | 5.7 K | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 10.39 B | ||||
| Total Asset | 6.3 B | ||||
| Retained Earnings | 2.75 B | ||||
| Working Capital | 1.42 B | ||||
| Current Asset | 193.04 M | ||||
| Current Liabilities | 81.49 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 6.3 B | ||||
| Last Dividend Paid | 0.26 |
About Qiagen NV Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Qiagen NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Qiagen NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Qiagen NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Qiagen NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.Moving against Qiagen Stock
| 0.79 | GSS | Genetic Signatures Earnings Call Next Week | PairCorr |
| 0.78 | OSL | Oncosil Medical Earnings Call This Week | PairCorr |
| 0.71 | CDT | Conduit Pharmaceuticals | PairCorr |
| 0.66 | HBIO | Harvard Bioscience | PairCorr |
| 0.52 | A | Agilent Technologies Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.
The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Will Life Sciences Tools & Services sector continue expanding? Could Qiagen diversify its offerings? Factors like these will boost the valuation of Qiagen NV. Anticipated expansion of Qiagen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Qiagen NV data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.219 | Dividend Share 0.263 | Earnings Share 2.04 | Revenue Per Share | Quarterly Revenue Growth 0.037 |
Investors evaluate Qiagen NV using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Qiagen NV's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Qiagen NV's market price to deviate significantly from intrinsic value.
It's important to distinguish between Qiagen NV's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Qiagen NV should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Qiagen NV's market price signifies the transaction level at which participants voluntarily complete trades.